BioPredictive

BioPredictive is a young French start-up of Paris-University, created in 2002, whose main purpose is studying, designing, and developing biological tests. The concept is to improve the management of disease by replacing invasive strategies with noninvasive strategies. The first step has been the discovery and development of biochemical markers of c... hronic liver disease. Fibrotest is a biochemical marker of liver fibrosis and Actitest is a marker of inflammation and necrosis of the liver. BioPredictive is the company licensed by Assistance Public-Hopitaux de Paris (AP-HP) to use and sell the FibroTest and ActiTest noninvasive tests. These tests will be available exclusively from LabCorp in the U.S. under the name HCV FibroSUREÔ. One year after FibroTest-ActiTest commercial launch, BioPredictive performs over 2,000 tests per month and services 150 private and 12 public hospital laboratories in France, Switzerland, Portugal, Morocco and Mexico. Our partners are Paris Biotech, AP-HP, CNRS, Universites Paris 5 and Paris 6. BioPredictive was rewarded by the French research ministry at the Fourth National Contest of innovative companies.Read More